RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
Recruiting · NCT06142058 · Registry updated 2023-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC | non-small cell lung carcinoma | Recruiting | Not stated | 2023-11-21 | NCT06142058 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xueqin Yang | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Center, Dapping Hospital, Army Medical Center of PLA | Chongqing | China | 1 |